The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Amed Salah since 2006.
The trader's CIK number is 1237250.
At the time of the last reporting, Amed Salah was the Sr.VP, R&D of Barr Pharmaceuticals Inc. (stock ticker symbol BRL).
Also see all insider trading activities at Barr Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2006 | BRL | 0 | $0 | 77,141 | $5,049,386 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2006-01-10 | BRL | Sale | 45,800 | 66.62 | 3,051,287 |
2006-01-09 | BRL | Sale | 4,804 | 66.53 | 319,634 |
2006-01-04 | BRL | Sale | 26,537 | 63.25 | 1,678,465 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Amed Salah (Sr.VP, R&D of Barr Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.